🇺🇸 FDA
Patent

US 11865186

Gene therapy treatment of atrial fibrillation

granted A61KA61K31/713A61K38/00

Quick answer

US patent 11865186 (Gene therapy treatment of atrial fibrillation) held by Northwestern University expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/713, A61K38/00, A61K38/1709, A61K48/005